MN1 Gene Meningioma MN1 Deficiency Related Genetic Test sale cost 4400 AED
JAK2 Gene Leukemia Acute Myelogenous Genetic Test sale cost 4400 AED JAK2 Gene Leukemia Acute Myelogenous Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MPL Gene MPL Selective Sequencing of Exon 10 Genetic Test sale cost 4400 AED MPL Gene MPL Selective Sequencing of Exon 10 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MN1 Gene Meningioma MN1 Deficiency Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MN1 gene is associated with a type of brain tumor known as meningioma. Meningiomas are tumors that arise from the meninges, the membranous layers surrounding the brain and spinal cord. While many meningiomas are benign and grow slowly, some can be malignant and aggressive. The MN1 gene plays a role in cell cycle regulation and its mutations or alterations can contribute to the development and progression of meningiomas.

The MN1 Deficiency Related Genetic Test is a specialized diagnostic tool designed to detect mutations or deficiencies in the MN1 gene. This test is crucial for individuals who are at risk of developing meningiomas or for those who have been diagnosed with a meningioma, as it helps in understanding the genetic basis of the tumor. By identifying specific genetic alterations, healthcare providers can better predict the behavior of the tumor, including its potential growth rate and likelihood of recurrence after treatment. This information is invaluable for tailoring treatment plans to the individual’s specific genetic profile, potentially improving outcomes.

The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the MN1 Deficiency Related Genetic Test is 4400 AED. DNA Labs UAE employs state-of-the-art technology and highly skilled professionals to ensure accurate and reliable test results. The facility provides a comprehensive service, including pre-test counseling to discuss the implications of the test results and post-test support to help patients and their families understand the next steps in management or treatment.

In summary, the MN1 Deficiency Related Genetic Test is a vital diagnostic tool for individuals with meningioma or at risk of developing this type of tumor. Available at DNA Labs UAE for 4400 AED, this test offers insights into the genetic factors contributing to meningioma development, aiding in personalized treatment planning and potentially improving patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MN1 Gene Meningioma MN1 Deficiency Related Genetic Test

About the Test

The MN1 gene meningioma MN1 deficiency-related genetic test offered at DNA Labs UAE is a comprehensive genetic test designed to identify genetic alterations in the MN1 gene that may be associated with meningioma development.

Test Components

  • Test Name: MN1 Gene Meningioma MN1 Deficiency Related Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre-Test Information

Before undergoing the MN1 gene meningioma MN1 deficiency-related genetic test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MN1 gene meningioma, MN1 deficiency-related NGS genetic DNA test gene MN1.

Test Details

The MN1 gene encodes for a protein called MN1 transcriptional co-activator, which plays a role in the regulation of gene expression and various cellular processes, including cell proliferation and differentiation. Meningioma is a type of tumor that originates from the meninges, the protective membranes surrounding the brain and spinal cord.

In some cases, abnormalities in the MN1 gene, such as gene fusions or mutations, have been identified in certain meningiomas. These abnormalities can lead to the overexpression or altered function of the MN1 protein, potentially contributing to the development and progression of meningiomas.

NGS (Next-Generation Sequencing) genetic testing is a cutting-edge genetic testing method that allows for the simultaneous analysis of multiple genes or even the entire genome. It utilizes high-throughput sequencing technologies to rapidly and efficiently sequence DNA or RNA samples.

NGS genetic testing can be utilized to identify specific genetic alterations, such as gene fusions or mutations, in the MN1 gene or other genes associated with meningioma. The MN1 deficiency-related NGS genetic test specifically focuses on identifying genetic alterations in the MN1 gene that may be linked to meningioma development.

This comprehensive genetic test can provide crucial information about the presence of MN1 gene abnormalities, aiding in the diagnosis, prognosis, and treatment planning for individuals with meningioma.

Test Name MN1 Gene Meningioma MN1 deficiency related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MN1 Gene Meningioma, MN1 deficiency related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MN1 Gene Meningioma, MN1 deficiency related NGS Genetic DNA Test gene MN1
Test Details

MN1 gene is a gene that encodes for a protein called MN1 transcriptional co-activator. This protein plays a role in the regulation of gene expression and is involved in various cellular processes, including cell proliferation and differentiation.

Meningioma is a type of tumor that arises from the meninges, the protective membranes that surround the brain and spinal cord. MN1 gene abnormalities, such as gene fusions or mutations, have been identified in a subset of meningiomas. These abnormalities can lead to the overexpression or altered function of the MN1 protein, which may contribute to the development and progression of meningiomas.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technologies to rapidly and efficiently sequence DNA or RNA samples. NGS genetic testing can be used to identify specific genetic alterations, such as gene fusions or mutations, in the MN1 gene or other genes associated with meningioma.

A MN1 deficiency-related NGS genetic test specifically focuses on identifying genetic alterations in the MN1 gene that may be associated with meningioma development. This test can provide important information about the presence of MN1 gene abnormalities, which can help in the diagnosis, prognosis, and treatment planning for individuals with meningioma.

SKU: TEST-4527